Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

Recent & Breaking News (CSE:BNXT)

XPhyto Provides Update on Parkinsons' Transdermal Patch

Newsfile August 25, 2020

These Are Some of the Top Companies Racing to Keep up with Diagnostic Test Demand

Livemoney August 14, 2020

XPhyto Announces OTCQB Venture Market Listing

Accesswire August 14, 2020

Pandemic: Demand for Diagnostic Testing is Still Outweighing Supply

Livemoney August 10, 2020

XPhyto Provides Update on Covid-19 Rapid Test Commercialization

Accesswire August 10, 2020

XPhyto To Present at Wall Street Reporter's "Next Super Stock" Livestream Conference on August 10th, 2020

Accesswire August 6, 2020

Comparing COVID 19 Test Kits: Sona vs XPhyto

Marc Davis July 24, 2020

XPhyto Therapeutics Corp.: COVID-19 Rapid Screening Test Prototype Validation

Newsfile July 6, 2020

XPhyto Engages Knox Communications Inc. for Investor Relations Services

Newsfile July 1, 2020

Infectious Disease Oral Biosensor Function Confirmed

Accesswire June 29, 2020

XPhyto Therapeutics Corp.: Infectious Disease Oral Screening Test Advancement

Newsfile June 15, 2020

XPhyto's Diagnostic Partners Receive BMBF Grant for Infectious Disease Screening Tests

Newsfile June 10, 2020

Parkinson's Generic Transdermal Drug Delivery System

Accesswire June 8, 2020

Oettinger Brewery Signs Exclusive Agreement with Xphyto for Cannabis-Infused Beverages

Accesswire May 12, 2020

Infectious Disease Oral Dissolvable Biosensor Development

Accesswire April 22, 2020

Why XPhyto is OUTPERFORMING EVERYONE

Marc Davis April 21, 2020

Covid-19 Screening Test, Oral Thin Film Biosensor Products and High-Throughput Biosensor Identification Platform

Accesswire April 20, 2020

Exclusive Advisory Agreement Signed for COVID-19 and Host Cell Interactions

Accesswire March 25, 2020

RETRANSMISSION: COVID-19 Test and Development Programs Update

Newsfile March 23, 2020

XPhyto Announces COVID-19 Test and Development Programs Update

Newsfile March 20, 2020